Citation Impact
Citing Papers
Predictive factors for diabetic foot ulceration: a systematic review
2012
Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
2016
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial
2014
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
2016
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
2019
Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial
2016
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial
2015
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
2015
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
2018
The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects
2005
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Severe Hypoglycemia and Risks of Vascular Events and Death
2010 Standout
Rationale, Design, and Methods for Glycemic Control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
2006
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Metformin as a Tool to Target Aging
2016
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
2010
Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population
2008
The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review
2012
The metabolic syndrome
2010 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
2015
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
2013
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
2016
The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis
2015
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
2017
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
2012
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Cardiovascular effects of gliptins
2013
The Relationship between Health‐Related Quality of Life and Weight Loss
2001
Cognitive behaviour therapy for eating disorders: a “transdiagnostic” theory and treatment
2003 Standout
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors
2010
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
2013
Health‐Related Quality of Life Varies among Obese Subgroups
2002
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
2014 StandoutNature
Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis
2017
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
2012
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Type 2 diabetes
2017 Standout
Type 2 Diabetes: Assessing the Relative Risks and Benefits of Glucose-lowering Medications
2010
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
2015
The potential for renoprotection with incretin-based drugs
2014
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
2010
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
2012 Standout
Development of a Brief Measure to Assess Quality of Life in Obesity
2001
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
2021
An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers
2015
Do Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Cause Heart Failure?
2014
Management of Obesity in Adults: European Clinical Practice Guidelines
2008
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
2010
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy
2008
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
2016
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
2014
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer
2014
Do sulphonylureas still have a place in clinical practice?
2018
What We Talk About When We Talk About Fat
2014 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
2015
Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans
2008
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial
2019
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
2009
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
2017
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2015
Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study
2010
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
European Guidelines for Obesity Management in Adults
2015 Standout
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
2008
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
2010
Shared decision making in endocrinology: present and future directions
2016
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
2017
Appetite Suppressants, Cardiac Valve Disease and Combination Pharmacotherapy
2008
Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
2017
Metabolic Syndrome and Incident Diabetes
2008
Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
2011
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials
2015
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
2015
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women
2010
Efficacy and safety of glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: A systematic review and mixed‐treatment comparison analysis
2016
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Is There a Link Between Liraglutide and Pancreatitis? A Post Hoc Review of Pooled and Patient-Level Data From Completed Liraglutide Type 2 Diabetes Clinical Trials
2014
Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal‐F1)
2013
Cardiovascular Biology of the Incretin System
2012
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
2017
Pharmacological and surgical treatment of obesity.
2004
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
2016
Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
2007
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus
2018
A meta‐analysis comparing clinical effects of short‐ or long‐acting GLP ‐1 receptor agonists versus insulin treatment from head‐to‐head studies in type 2 diabetic patients
2016
Triple therapy in type 2 diabetes; a systematic review and network meta-analysis
2015
Semaglutide for type 2 diabetes mellitus: A systematic review and meta‐analysis
2018
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Diabetes and Cancer
2010 Standout
Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review
2015
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Behavioral Programs for Type 1 Diabetes Mellitus
2015
Spermidine in health and disease
2018 StandoutScience
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
2015
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
2015
New photosensitizers for photodynamic therapy
2016 Standout
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)‐TIMI 53 trial
2013
Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis
2016
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus
2016
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
2011
A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
2015
The Metabolic Syndrome
2008 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Do we know the true mechanism of action of the DPP ‐4 inhibitors?
2017
A review of dipeptidyl peptidase‐4 inhibitors. Hot topics from randomized controlled trials
2018
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
2008
Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence
2019
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
2022
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Head‐to‐head comparison of dipeptidyl peptidase‐IV inhibitors and sulfonylureas – a meta‐analysis from randomized clinical trials
2013
Industry sponsorship and research outcome
2017 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors
2015
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
2019
The effect of weight loss on health‐related quality of life: systematic review and meta‐analysis of randomized trials
2013
Works of Edoardo Mannucci being referenced
The Diabetic Person Beyond a Foot Ulcer
2008
Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials
2012
Psychopathological and clinical features of outpatients with an eating disorder not otherwise specified
2001
Testosterone, cardiovascular disease and the metabolic syndrome
2011
Metabolic Syndrome and Cardiovascular Mortality in Older Type 2 Diabetic Patients: A Longitudinal Study
2008
Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials
2008
Sexual dysfunction in subjects with Klinefelter’s syndrome
2009
All‐cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides
2003
Dipeptydil peptidase-4 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials
2009
Failure of acupuncture in the treatment of obesity: A pilot study
1999
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze‐Bagno A Ripoli study
2007
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients
2007
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
2014
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells
2010
Quality of life and overweight
1999
Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials
2010
Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart disease
2007
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
2008
Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target
2017
The metabolic syndrome in treatment-seeking obese persons
2004
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
2011
Liver enzymes and risk of diabetes and cardiovascular disease: Results of the Firenze Bagno a Ripoli (FIBAR) study
2008
Glycaemic efficacy of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors as add‐on therapy to metformin in subjects with type 2 diabetes—a review and meta analysis
2012
Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study—the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study
2013
Three‐year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin
2006
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials
2016
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials
2011
Prevention of cardiovascular disease through glycemic control in type 2 diabetes: A meta-analysis of randomized clinical trials
2009
Type 2 diabetes mellitus and testosterone: a meta-analysis study
2010
Dipeptidyl peptidase-4 inhibitors and heart failure: A meta-analysis of randomized clinical trials
2014
Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
2013
Metformin Beyond Diabetes: New Life for an Old Drug
2006
Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus
2005
Winners and losers at the rosiglitazone gamble
2008
DPP-4 Inhibitors and Lipids: Systematic Review and Meta-Analysis
2011
Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
2015
Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients
1996
Long-term interactive group education for type 1 diabetic patients
2005
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study
2004
Fluoxetine and Fluvoxamine Combined with Individual Cognitive-Behaviour Therapy in Binge Eating Disorder: A One-Year Follow-Up Study
2001
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials
2017
Glucagon-like peptide-1 receptor agonists and pancreatitis: A meta-analysis of randomized clinical trials
2014
Sulphonylureas and cancer: a case–control study
2008
Predictors of response to dipeptidyl peptidase‐4 inhibitors: evidence from randomized clinical trials
2011
Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk
2008
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: A meta-analysis
2007
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials
2020
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials
2017
Cholelithiasis in patients treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials
2020
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials
2009
Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
2017
[Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].
1998
Low Levels of Androgens in Men with Erectile Dysfunction and Obesity
2008
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
2012
Testosterone and Metabolic Syndrome: A Meta-Analysis Study
2010
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
2015
Efficacy and safety of sodium glucose co‐transport‐2 inhibitors in type 2 diabetes: a meta‐analysis of randomized clinical trials
2013
Dipeptidyl peptidase‐4 inhibitors and pancreatitis risk: a meta‐analysis of randomized clinical trials
2013
A meta‐analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes
2014
Effect of Metformin on Glucagon-Like Peptide 1 (GLP-1) and Leptin Levels in Obese Nondiabetic Subjects
2001
Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes
2008
Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk: a meta‐analysis of randomized clinical trials
2013
Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): D ata from randomized controlled trials
2017
Incidence and Risk Factors for Stroke in Type 2 Diabetic Patients
2007
Low Testosterone is Associated with an Increased Risk of MACE Lethality in Subjects with Erectile Dysfunction
2010
Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures
2011
NCEP-ATPIII-Defined Metabolic Syndrome, Type 2 Diabetes Mellitus, and Prevalence of Hypogonadism in Male Patients with Sexual Dysfunction
2007
Incretin-based therapies and cardiovascular risk
2012
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
2010
Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials
2011
Pulse Pressure and Prediction of Incident Foot Ulcers in Type 2 Diabetes
2009
Long‐term treatment with Sitagliptin, a dipeptidyl peptidase‐4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2‐dimethylhydrazine‐induced rats
2013
Testosterone Supplementation and Sexual Function: A Meta-Analysis Study
2014
Rosiglitazone and Risk of Cancer
2008
Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
2013
Effects of a Short Educational Program for the Prevention of Foot Ulcers in High-Risk Patients: A Randomized Controlled Trial
2015